Argent Trust Co

SEC CIK: 0001625292
Latest filing: Aug 6, 2026

SEC filings (opens in a new tab)

CLDX holding history

Celldex Therapeutics, Inc. in every 13F filed by Argent Trust Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLDX overview All 13F holders of CLDX Full Q2 2026 holdings

Shares (Q2 2026): 6,204
Value: $230.9K
% of portfolio: <0.1%
Quarters held: 3; Since Q3 2025

Holdings of CLDX by Argent Trust Co, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	6,204	$230.9K	<0.1%	+6,204	New	Holders
Q1 2026	0	$0	0.0%	−8,481−100.0%	Sold out	Holders
Q4 2025	8,481	$230.3K	<0.1%	00.0%	Unchanged	Holders
Q3 2025	8,481	$219.4K	<0.1%	+8,481	New	Holders